Veradigm Launches an Ambient Scribe Advancement to Ease the Healthcare Administrative Burden

November 21, 2024

The AI-powered addition to the Veradigm Network can reduce documentation time, increase operational efficiency, and enhance patient care

CHICAGO--(BUSINESS WIRE)--Nov. 21, 2024-- Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the launch of Veradigm Ambient Scribe, an artificial intelligence (AI)-enabled ambient scribe platform designed to ease the documentation burden for healthcare providers.

By adding Veradigm Ambient Scribe to the Veradigm Network, Veradigm advances its efforts to provide insightful solutions that drive value for healthcare providers. The solution helps to alleviate the daily administrative burden while enhancing provider-patient interactions. Veradigm Ambient Scribe can allow clinicians to focus more on their patients and less on data entry, which can result in increasingly accurate documentation.

This new solution reinforces Veradigm’s ongoing commitment to improving the daily lives of healthcare providers through streamlined workflow efficiencies. Veradigm Ambient Scribe joins other solutions in the Veradigm portfolio designed to ease administrative burden through solutions such as automated medical chart retrieval, end-to-end payer-provider collaboration, and bi-directional connectivity between healthcare providers and life sciences organizations. Veradigm is advancing its dedication to simplifying healthcare by incorporating the responsible use of AI in its solution development.

“Veradigm Ambient Scribe is the solution I’ve been waiting for over the past decade, and it’s truly making a difference,” said Kent Wright, MD, Medical Director and Chief Clinical Integration Officer at State of Franklin Healthcare Associates. “It’s reducing our documentation time, and allows physicians get back to the core of medicine, which is providing quality patient care.”

Veradigm Ambient Scribe, powered by AvodahMed™, utilizes generative AI to automatically capture and transcribe real-time patient-provider interactions into structured medical notes. These notes are seamlessly integrated into Veradigm EHR, enabling providers to focus on patient care without the stress of administrative tasks.

“Veradigm Ambient Scribe marks a significant step forward in our goal of driving value for providers, easing their administrative burden while supporting their ability to deliver higher quality patient care,” said Tom Langan, Interim CEO of Veradigm. “With this addition to the Veradigm Network, we’re bringing the latest advancements of AI directly to clinicians, allowing them to reclaim valuable time and enhance the overall quality of their practice.”

Veradigm Ambient Scribe is currently available to Veradigm EHR customers.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

About Avodah:

Avodah is an advanced artificial intelligence technology company committed to enhancing human connection through innovative solutions. With divisions in digital health and language translation, Avodah is dedicated to developing products that address complex challenges and improve outcomes across various sectors. AvodahMed, the digital health division, focuses on transforming how physicians and patients interact by providing state-of-the-art tools for healthcare professionals. Experience a world where everyone is seen, known and understood. To learn more about Avodah and AvodahMed, please visit www.Avodah.com and www.Avodahmed.com.

© 2024 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@veradigm.com

Media:
Stephanie Bevan
336-406-3924
stephanie.bevan@veradigm.com

Source: Veradigm

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
jenny.gelinas@veradigm.com